Quality of oral anticoagulation in patients with atrial fibrillation: A cross-sectional study in general practice

References

• Benavente O, Hart R, Koudstaal P, Laupacis A, McBride R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 2000; 2: CD001927
   Google Scholar
• Evans A, Kalra L. Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice?. Arch Intern Med 2001; 161: 1443–7
   PubMed Web of Science ®Google Scholar
• Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995; 333: 11–7
   PubMed Web of Science ®Google Scholar
• van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med 1993; 153: 1557–62
   PubMed Web of Science ®Google Scholar
• Guidelines on oral anticoagulation. third edition. Br J Haematol 1998;101:374–87.
   Google Scholar
• Gadisseur AP, van der Meer FJ, Adriaansen HJ, Fihn SD, Rosendaal FR. Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon. Br J Haematol 2002; 117: 940–6
   PubMed Web of Science ®Google Scholar
• Fihn SD, Gadisseur AA, Pasterkamp E, van der Meer FJ, Breukink-Engbers WG, Geven-Boere LM, et al. Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon. Thromb Haemost 2003; 90: 260–6
   PubMed Web of Science ®Google Scholar
• Wittkowsky AK. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions. Semin Vasc Med 2003; 3: 221–30
   PubMedGoogle Scholar
• Breukink-Engbers WG. Monitoring therapy with anticoagulants in the Netherlands. Semin Thromb Hemost 1999; 25: 37–42
   Google Scholar
• Rose PE, Fitzmaurice D. New approaches to the delivery of anticoagulant services. Blood Rev 1998; 12: 84–90
   Google Scholar
• Morsdorf S, Leipnitz G, Pindur G, Schenk JF, Erdlenbruch W, Krischek B, et al. Improved therapeutic safety of oral anticoagulant therapy in Germany: the Saarland model. Semin Thromb Hemost 1999; 25: 49–55
   Google Scholar
• Mermans D. Anticoagulatie in de huisartsenpraktijk, een evaluatie. Huisarts Nu 2001; 2: 4–9
   Google Scholar
• Malik AK, Taylor AJ. Can warfarin randomized trials be reproduced in'real life'? Adherence to warfarin guidelines for intensity of anticoagulation in a university-based warfarin clinic. South Med J 2000; 93: 58–61
   PubMedGoogle Scholar
• Taylor FC, Gaminara E, Cohen H, Ramsay M, Miller D. Evaluation of a nurse specialist anticoagulant service. Clin Lab Haem 1997; 19: 267–72
   Google Scholar
• Poller L, Shiach CR, MacCallum PK, Johansen AM, Munster AM, Magalhaes A, et al. Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation. Lancet 1998; 352: 1505–9
   PubMed Web of Science ®Google Scholar
• Pengo V, Barbero F, Banzato A, Garelli E, Noventa F, Biasiolo A, et al. A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses. Thromb Haemost 1997; 77: 839–44
   Google Scholar
• Fitzmaurice DA, Hobbs FD, Murray ET, Holder RL, Allan TF, Rose PE. Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: a randomized, controlled trial. Arch Intern Med 2000; 160: 2343–8
   PubMedGoogle Scholar
• Hippisley-Cox J, Pringle M, Coupland C, Hammersley V, Wilson A. Do single handed practices offer poorer care? Cross sectional survey of processes and outcomes. Br Med J 2001; 323: 320–3
   PubMedGoogle Scholar
• Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med 2003; 139: 893–900
   PubMed Web of Science ®Google Scholar
• The European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 1995; 333: 5–10
   PubMedGoogle Scholar
• Palareti G, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, et al. Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy). Thromb Haemost 1997; 78: 1438–43
   PubMed Web of Science ®Google Scholar
• Claes N, Buntinx F, Vijgen J, Arnout J, Vermylen J, Fieuws S, et al. Quality assessment of oral anticoagulation in Belgium, as practiced by a group of general practitioners. Acta Cardiol 2005; 60: 247–52
   Web of Science ®Google Scholar
• Claes N, Buntinx F, Vijgen J, Arnout J, Vermylen J, Fieuws S, et al. The Belgian Improvement Study on Oral Anticoagulation Therapy: a randomized clinical trial. Eur Heart J 2005; 26: 2159–65
   Google Scholar